Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Che C Colpitts

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Journal of Virology|May 3, 2014
A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycansChe C Colpitts, Luis M Schang
Nature Reviews. Gastroenterology & Hepatology|October 7, 2015
Viral hepatitis: A new HCV cell culture model for the next clinical challengesChe C Colpitts, Thomas F Baumert
Cell Reports. Medicine|March 22, 2021
A dual antibody test for accurate surveillance of SARS-CoV-2 exposure ratesEmmanuelle V LeBlanc, Che C Colpitts
Gastroenterology|November 28, 2016
SMAD About Hepatitis C Virus Cell Entry and Liver DiseaseChe C Colpitts, Thomas F Baumert
Scientific Reports|July 28, 2022
The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus attachment inhibitorEmmanuelle V LeBlanc, Che C Colpitts
Viruses|August 19, 2016
Addressing the Challenges of Hepatitis C Virus Resistance and Treatment FailureChe C Colpitts, Thomas F Baumert
Cell|April 30, 2021
SARS-CoV-2 RNA: Exclusive friends and common foesEmmanuelle V LeBlanc, Che C Colpitts
Hepatology International|April 7, 2016
Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antiviralsChe C Colpitts, Thomas F Baumert
Pflugers Archiv : European Journal of Physiology|November 26, 2016
Claudins in viral infection: from entry to spreadChe C Colpitts, Thomas F Baumert
Cellular and Molecular Gastroenterology and Hepatology|December 12, 2025
The Use of Human Liver Chimeric Mice to Study Hepatitis C Virus Antibody Escape: Implications for Vaccine DevelopmentChe C Colpitts, Thomas F Baumert
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Journal of Virology|May 3, 2014
A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycansChe C Colpitts, Luis M Schang
Nature Reviews. Gastroenterology & Hepatology|October 7, 2015
Viral hepatitis: A new HCV cell culture model for the next clinical challengesChe C Colpitts, Thomas F Baumert
Cell Reports. Medicine|March 22, 2021
A dual antibody test for accurate surveillance of SARS-CoV-2 exposure ratesEmmanuelle V LeBlanc, Che C Colpitts
Gastroenterology|November 28, 2016
SMAD About Hepatitis C Virus Cell Entry and Liver DiseaseChe C Colpitts, Thomas F Baumert
Scientific Reports|July 28, 2022
The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus attachment inhibitorEmmanuelle V LeBlanc, Che C Colpitts
Viruses|August 19, 2016
Addressing the Challenges of Hepatitis C Virus Resistance and Treatment FailureChe C Colpitts, Thomas F Baumert
Cell|April 30, 2021
SARS-CoV-2 RNA: Exclusive friends and common foesEmmanuelle V LeBlanc, Che C Colpitts
Hepatology International|April 7, 2016
Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antiviralsChe C Colpitts, Thomas F Baumert
Pflugers Archiv : European Journal of Physiology|November 26, 2016
Claudins in viral infection: from entry to spreadChe C Colpitts, Thomas F Baumert
Cellular and Molecular Gastroenterology and Hepatology|December 12, 2025
The Use of Human Liver Chimeric Mice to Study Hepatitis C Virus Antibody Escape: Implications for Vaccine DevelopmentChe C Colpitts, Thomas F Baumert
Pageof 6